Suppr超能文献

通过靶向tat RNA的核酶对HIV-1复制进行靶向序列特异性抑制。

Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

作者信息

Sun L Q, Wang L, Gerlach W L, Symonds G

机构信息

R.W. Johnson Pharmaceutical Research Institute Sydney, NSW, Australia.

出版信息

Nucleic Acids Res. 1995 Aug 11;23(15):2909-13. doi: 10.1093/nar/23.15.2909.

Abstract

The structural motif formed between a hammerhead ribozyme and its substrate consists of three RNA double helices in which the sequence 5' to the XUY is termed helix I and the sequence 3' to the XUY helix III. Two hammerhead ribozymes targeted to the tat gene of HIV-1SF2 were designed to study target specificity and the potential effect of helix I mismatch on ribozyme efficacy both in vitro and in vivo. The first ribozyme (Rz1) targeted to the 5' splicing region of the tat gene was designed to cleave GUC*A. In HIV-1IIIB the A is changed to a G. The second ribozyme (Rz2) was targeted to the translational initiation region of the tat gene which is highly conserved among a variety of HIV-1 isolates, including both HIV-1SF2 and HIV-1IIIB. In vitro cleavage studies demonstrated that Rz1 efficiency cleaved HIV-1SF2 substrate RNA, but not HIV-1IIIB, presumably due to the base change from A to G. In contrast, Rz2 cleaved HIV-1SF2 or HIV-1IIIB substrate with equal efficiency. Both ribozymes were cloned into the 3' untranslated region of the neomycin gene (neo) within the pSV2neo vector and transfected into the SupT1 human CD4+ T cell line. Following selection, stable transfectants were challenged with either HIV-1SF2 or HIV-1IIIB virus. While Rz1-expressing cells were significantly protected from HIV-1SF2 infection, they exhibited no protection when infected with HIV-1IIIB virus. In contrast, Rz2 was effective in inhibiting the replication of both HIV-1SF2 and HIV-1IIIB in SupT1 cells. Expression of both ribozymes in these cells was demonstrated by Northern analysis. RT-PCR sequencing analysis confirmed the respective HIV-1 target sequence integrity. These data demonstrate the importance of the first base pair distal to the XUY within helix I of the hammerhead structure for both in vitro and in vivo ribozyme activities and imply that the effectiveness of the anti-HIV-1 ribozymes against appropriate target sequences is due to their catalytic activities rather than any antisense effect.

摘要

锤头状核酶与其底物之间形成的结构基序由三个RNA双螺旋组成,其中XUY 5'端的序列称为螺旋I,XUY 3'端的序列称为螺旋III。设计了两种靶向HIV-1 SF2 tat基因的锤头状核酶,以研究体外和体内的靶标特异性以及螺旋I错配对核酶效力的潜在影响。第一种核酶(Rz1)靶向tat基因的5'剪接区,设计用于切割GUC*A。在HIV-1 IIIB中,A变为G。第二种核酶(Rz2)靶向tat基因的翻译起始区,该区域在多种HIV-1分离株中高度保守,包括HIV-1 SF2和HIV-1 IIIB。体外切割研究表明,Rz1能有效切割HIV-1 SF2底物RNA,但不能切割HIV-1 IIIB,推测是由于碱基从A变为G。相比之下,Rz2能以相同效率切割HIV-1 SF2或HIV-1 IIIB底物。两种核酶都被克隆到pSV2neo载体中新霉素基因(neo)的3'非翻译区,并转染到SupT1人CD4+ T细胞系中。筛选后,用HIV-1 SF2或HIV-1 IIIB病毒攻击稳定转染子。虽然表达Rz1的细胞受到显著保护,免受HIV-1 SF2感染,但当感染HIV-1 IIIB病毒时,它们没有表现出保护作用。相比之下,Rz2在抑制SupT1细胞中HIV-1 SF2和HIV-1 IIIB的复制方面有效。通过Northern分析证实了这两种核酶在这些细胞中的表达。RT-PCR测序分析证实了各自HIV-1靶序列的完整性。这些数据证明了锤头状结构螺旋I中XUY远端第一个碱基对对于体外和体内核酶活性的重要性,并暗示抗HIV-1核酶对适当靶序列的有效性是由于它们的催化活性而非任何反义效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验